Anesiva, Inc. (ANSV) Receives FDA Approval for Supplemental New Drug Application to Expand Zingo(TM) Indication
Anesiva, Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved its supplemental New Drug Application (sNDA)…
Blog
China Voice Holding Corp. (CHVC.PK): SEC Completes Review of Form 10 Registration Statement
Today, China Voice Holding Corp. announced that it has received a letter from the Securities & Exchange Commission (SEC) that…
Axial Vector Energy Corporation (AXVC.PK): Discovering an Innovative Way to Capitalize on the Growing Wind Energy Market
A record 20,000 megawatts (MW) of wind power were installed worldwide in 2007, with the United States, Spain and China…
BWI Holdings, Inc. Approves a 5-1 Forward Stock Split
BWI Holdings, Inc. (OTCBB: BWIH), operating as Budget Waste Inc. (the "Company"), today announced that at the board of directors…
mPhase Technologies Inc. (XDSL.OB) is “One to Watch”
Trading on the OTCBB, mPhase Technologies, Inc. focuses on developing and commercializing a new battery technology. Headquartered in Little Falls,…
Thresher Industries Inc. (THRR.PK) is “One to Watch”
Headquartered in Hanford, California, Thresher Industries is a provider of aluminum and metal matrix composite alloy castings. The Company started…
WWA Group Inc. (WWAG.OB) is “One to Watch”
WWA Group Inc. is a company that trades and auctions transportation and industrial equipment worldwide. Through their wholly owned subsidiary,…
Hunt Gold Corp. (HGLC.PK) Updates Shareholders Regarding Current Operations and Future Plans
Less than two hours ago, Hunt Gold Corp. provided shareholders with a comprehensive update covering a variety of issues. Regarding…
Millennium Biotechnologies Group, Inc. (MBTG) Receives its Largest International Purchase Order from Greek Distributor
Today, Millennium Biotechnologies Group announced that Nutrimedica, S.A., an international nutritional supplement distributor, headquartered in Athens, Greece, has ordered its…
Anadys Pharmaceuticals, Inc. (ANDS) Stock Up More Than 90% After Release of Clinical Trial Results
Today before the opening bell, Anadys Pharmaceuticals, Inc. announced positive results from the first cohort of an ongoing Phase Ib…